Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | TDP2 | O95551 | 1/20 | 0.54 |
| ▸ | CRHBP | P24387 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 2/20 | 0.49 |
| ▸ | PTPRC | P08575 | 1/20 | 0.46 |
| ▸ | S100A4 | P26447 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.45 |
| ▸ | PNMT | P11086 | 2/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9811059 | 0.93 | TLR9 (0.62) | TLR9MEN1LMNAMAPTRAB9A | |
| SCHEMBL987760 | 0.89 | TLR9 (0.79) | TLR9MEN1LMNAMAPTRAB9A | |
| SCHEMBL30049268 | 0.89 | TLR9 (0.79) | TLR9MEN1LMNAMAPTRAB9A | |
| 2-Nitrofluorene SCHEMBL29450702 | 0.81 | MAPT (0.68) | TLR9MEN1LMNAMAPTRAB9A | |
| 2-Nitrofluorene SCHEMBL644332 | 0.81 | MAPT (0.68) | TLR9MEN1LMNAMAPTRAB9A | |
| SCHEMBL5030144 | 0.79 | TLR9 (0.66) | TLR9MEN1LMNAMAPTRAB9A | |
| SCHEMBL2374341 | 0.79 | MAPT (1.00) | TLR9MEN1LMNAMAPTRAB9A | |
| SCHEMBL8927848 | 0.79 | TLR9 (0.66) | TLR9MEN1LMNAMAPTRAB9A | |
| SCHEMBL5528874 | 0.79 | TLR9 (0.66) | TLR9MEN1LMNAMAPTRAB9A | |
| SCHEMBL18849687 | 0.79 | TLR9 (0.66) | TLR9MEN1LMNAMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113711007-B | Method for determining generation source of microparticles in atmosphere | 株式会社岛津制作所 | 2024-10-25 | — | — | CN | claimed |
| CN-113711007-A | Method for determining generation source of fine particles in atmosphere | 株式会社岛津制作所 | 2021-11-26 | — | — | CN | claimed |
| WO-2020217543-A1 | METHOD FOR IDENTIFYING GENERATION SOURCES OF FINE PARTICULATES IN ATMOSPHERE | 早川 和一 | 2020-10-29 | — | — | WO | claimed |
| CN-113711007-B | Method for determining generation source of microparticles in atmosphere | 株式会社岛津制作所 | 2024-10-25 | — | — | CN | disclosed |
| US-20230149340-A1 | BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS | MICROBION CORPORATION | 2023-05-18 | — | — | US | disclosed |
| US-11564903-B2 | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications | MICROBION CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220016132-A1 | BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES | MICROBION CORPORATION | 2022-01-20 | — | — | US | disclosed |
| CN-113711007-A | Method for determining generation source of fine particles in atmosphere | 株式会社岛津制作所 | 2021-11-26 | — | — | CN | disclosed |
| US-10960012-B2 | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses | MICROBION CORPORATION (US) | 2021-03-30 | — | — | US | disclosed |
| US-10835510-B2 | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications | MICROBION CORPORATION (US) | 2020-11-17 | — | — | US | disclosed |
| WO-2020217543-A1 | METHOD FOR IDENTIFYING GENERATION SOURCES OF FINE PARTICULATES IN ATMOSPHERE | 早川 和一 | 2020-10-29 | — | — | WO | disclosed |
| US-20080268514-A1 | Liquid matrix dissolved or dissociated in biocompatible solvent and stabilizer in contact without refrigeration for one day | EXACT SCIENCES CORPORATION | 2008-10-30 | — | — | US | disclosed |
| EP-1951868-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | Biomatrica, Inc. (US) | 2008-08-06 | — | — | EP | disclosed |
| US-20080176209-A1 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | BIOMATRICA, INC. (US) | 2008-07-24 | — | — | US | disclosed |
| CN-101035620-A | Integration of sample storage and sample management for life sciences | BIOMATRICA INC (US) | 2007-09-12 | — | — | CN | disclosed |
| WO-2007075253-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | BIOMATRICA, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| EP-1737573-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | Biomatrica, Inc. (US) | 2007-01-03 | — | — | EP | disclosed |
| US-20060099567-A1 | Desolventizing, dehydration, dryness; for automated storing, tracking retrieving and analyzing of nucleic acid samples; refrigeration-free | BIOMATRICA, INC. (US) | 2006-05-11 | — | — | US | disclosed |
| US-20050276728-A1 | Desolventizing, dehydration, dryness; for automated storing, tracking retrieving and analyzing of nucleic acid samples; refrigeration-free | BIOMATRICA, INC. (US) | 2005-12-15 | — | — | US | disclosed |
| WO-2005113147-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | BIOMATRICA, INC. (US) | 2005-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10960012-B2 | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses | TST, BTD, BTF3 | TLR9 1158/4885MEN1 1986/4885LMNA 4868/4885 |
| US-20220016132-A1 | BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES | TST, BTD, BTF3 | TLR9 1158/4885MEN1 1986/4885LMNA 4868/4885 |
| US-20230149340-A1 | BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS | TST, BTD, BTF3 | TLR9 467/4885MEN1 3276/4885LMNA 4876/4885 |
| US-20060099567-A1 | Desolventizing, dehydration, dryness; for automated storing, tracking retrieving and analyzing of nucleic acid samples; refrigeration-free | DNASE1, DCTD, DNASE1L3 | TLR9 4221/4885MEN1 3794/4885LMNA 860/4885 |
| US-20080176209-A1 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | NEFM, DNASE1, DCTD | TLR9 3851/4885MEN1 2408/4885LMNA 191/4885 |
| US-10835510-B2 | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications | TST, BTD, BTF3 | TLR9 467/4885MEN1 3276/4885LMNA 4876/4885 |
| US-11564903-B2 | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications | TST, BTD, BTF3 | TLR9 467/4885MEN1 3276/4885LMNA 4876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.